Back to search
FDAFDA · Food and drugs·Recall number D-0187-2025

Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03

Published January 15, 2025 · Recall initiated: December 18, 2024

Summary

FDA records drug Class II recall D-0187-2025, published January 15, 2025 and initiated December 18, 2024. Recalling firm: Granules Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 96 Bottles; Lot: Lot#: GPC240763B, Exp. Date 6/17/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email if COLCHICINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
COLCHICINE
Manufacturer
Granules Pharmaceuticals Inc.
Distributor
Nationwide within the United States
UPC
0370010001039
Lot
Lot#: GPC240763B, Exp. Date 6/17/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03 recalled?

Yes. FDA published recall D-0187-2025 on January 15, 2025. Reported hazard: Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: COLCHICINE. UPC: 0370010001039.